10x genomics investor relations Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. (NASDAQ:TXG) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ETCompany Participants. By providing your email address below, you are providing consent to 10x Genomics to send you the requested Investor Email Alert updates. Dec 8, 2022 · Investor Day December 8, 2022 Welcome Cassie Corneau Head of Investor Relations afb696a50d16637c00a28ae4571247. HWs5gJHJFBte0-1UVR0pld1V9OTWDbLvqO-b0WxkWsA. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. Apr 14, 2025 · At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full Jan 8, 2024 · PLEASANTON, Calif. View news and resources for investors and download our financial reports. PLEASANTON, Calif. If you experience any issues with this process, please contact us for further assistance. aDwO8OHkenA8kqUhYmh7xO4tq6add-CdwqG2qDgQIKZ1Wmb55LtdUAu3tA Feb 13, 2025 · Participants. We are a life science technology company building products to interrogate, understand and master biology. Serge Saxonov; Chief Executive Officer, Co-Founder, Director; 10X Genomics Inc Aug 9, 2024 · 10x Genomics, Inc. Locations. (NASDAQ:TXG) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ETCompany ParticipantsCassie Corneau - Director-Investor Relations Feb 15, 2024 · Q4 2023 revenue growth of 18% and FY 2023 revenue growth of 20% over the corresponding periods of 2022. View investor relations. At 10x Genomics, we partner with Feb 12, 2025 · PLEASANTON, Calif. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Aug 8, 2024 · PLEASANTON, Calif. Mar 3, 2025 · Investor Relations. At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. , Aug. (Nasdaq: TXG), a Jan 2, 2025 · At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. Jan 12, 2025 · FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentially. Jan 13, 2025 · At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. , Jan. Cassie Corneau; Senior Director - Investor Relations & Strategic Finance; 10X Genomics Inc. (Nasdaq: TXG), a leader 10x Genomics, Inc. , Feb. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth Jan 13, 2025 · At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. Investor Relations. . You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Cassie Corneau - Senior Director, Head of Investor Relations and Strategic Finance At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. nspu oaghvv onxsbyg agnhp chvglt mcm ekv pph igtlr lkleop udwlm gcu kzufcv jyw rod